Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126642191 | 12664219 | 1 | I | 2002 | 20160809 | 20160818 | 20160818 | EXP | CH-VIIV HEALTHCARE LIMITED-CH2016GSK118471 | VIIV | CALMY A, VAN DELDEN C, GIOSTRA E, JUNET C, BRANDT LR, YERLY S ET AL. HIV-POSITIVE-TO-HIV-POSITIVE LIVER TRANSPLANTATION. AMERICAN JOURNAL OF TRANSPLANTATION. 2016;16:2473-2478 | 75.00 | YR | M | Y | 0.00000 | 20160818 | OT | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126642191 | 12664219 | 1 | PS | ZIDOVUDINE. | ZIDOVUDINE | 1 | UNK | 19655 | |||||||||||
| 126642191 | 12664219 | 2 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | UNK | 0 | |||||||||||
| 126642191 | 12664219 | 3 | SS | ABACAVIR. | ABACAVIR | 1 | UNK | U | 0 | ||||||||||
| 126642191 | 12664219 | 4 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | U | 0 | |||||||||||
| 126642191 | 12664219 | 5 | SS | EMTRICITABINE | EMTRICITABINE | 1 | U | 0 | |||||||||||
| 126642191 | 12664219 | 6 | SS | INDINAVIR | INDINAVIR | 1 | UNK | 0 | |||||||||||
| 126642191 | 12664219 | 7 | C | NEVIRAPINE. | NEVIRAPINE | 1 | 0 | ||||||||||||
| 126642191 | 12664219 | 8 | C | LOPINAVIR | LOPINAVIR | 1 | 0 | ||||||||||||
| 126642191 | 12664219 | 9 | C | RALTEGRAVIR. | RALTEGRAVIR | 1 | 0 | ||||||||||||
| 126642191 | 12664219 | 10 | C | DOLUTEGRAVIR | DOLUTEGRAVIR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126642191 | 12664219 | 1 | HIV infection |
| 126642191 | 12664219 | 2 | HIV infection |
| 126642191 | 12664219 | 3 | HIV infection |
| 126642191 | 12664219 | 4 | HIV infection |
| 126642191 | 12664219 | 5 | HIV infection |
| 126642191 | 12664219 | 6 | HIV infection |
| 126642191 | 12664219 | 7 | HIV infection |
| 126642191 | 12664219 | 8 | HIV infection |
| 126642191 | 12664219 | 9 | HIV infection |
| 126642191 | 12664219 | 10 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126642191 | 12664219 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126642191 | 12664219 | Drug resistance | |
| 126642191 | 12664219 | Pathogen resistance | |
| 126642191 | 12664219 | Viral mutation identified | |
| 126642191 | 12664219 | Virologic failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126642191 | 12664219 | 1 | 1996 | 2002 | 0 | |
| 126642191 | 12664219 | 2 | 1996 | 2002 | 0 | |
| 126642191 | 12664219 | 6 | 1996 | 2002 | 0 |